Table 4.

Logistic regression analysis of lipid index

	Analysis
	Single		Multiple
	OR (95% CI)	p-value	OR (95% CI)	p-value
Age (years)	0.40 (0.13–1.22)	0.106
Male	1.00 (0.34–2.92)	1.000
Body mass index	2.67 (0.92–7.77)	0.072
Diabetes mellitus	1.00 (0.35–2.82)	1.000
Hypertension	1.93 (0.70–5.32)	0.206
Dyslipidemia	0.56 (0.16–1.93)	0.360
Chronic kidney disease	1.93 (0.62–6.07)	0.259
Current smoker	1.30 (0.47–3.59)	0.607
Obstructive sleep apnea	2.67 (0.92–7.77)	0.072
Apnea hypopnea index	6.30 (1.61–24.7)	0.008	8.08 (1.70–38.5)	0.009
Family history of coronary artery disease	2.67 (0.63–11.3)	0.183
History of PCI or CABG	0.43 (0.16–1.15)	0.092
History of myocardial infarction	0.25 (0.08–0.80)	0.020
Prior statin use	0.20 (0.07–0.59)	0.004	0.18 (0.05–0.62)	0.007
Prior aspirin use	0.44 (0.17–1.16)	0.096
Prior clopidogrel use	0.35 (0.12–1.07)	0.065
Prior ACEI or ARB	0.42 (0.14–1.24)	0.117
Prior calcium channel blocker use	0.66 (0.24–1.86)	0.435
Prior beta blocker use	0.77 (0.28–2.11)	0.607
Prior eicosapentaenoic acid	0.36 (0.07–2.02)	0.247
Prior ezetimibe	0.23 (0.02–2.15)	0.197
Hemoglobin (g/dl)	2.36 (0.81–6.93)	0.117
HbA1c (%)	2.67 (0.63–11.3)	0.183
Glucose (mg/dl)	3.63 (1.20–10.9)	0.022	6.22 (1.62–23.8)	0.008
LDL-C (mg/dl)	2.01 (0.77–5.22)	0.152
Triglyceride (mg/dl)	1.83 (0.61–5.47)	0.277
HDL-C (mg/dl)	0.60 (0.19–1.91)	0.385
LDL-C to HDL-C ratio	2.67 (0.92–7.77)	0.072
Acute coronary syndrome	2.65 (0.99–7.11)	0.054
ST-elevation myocardial infarction	2.18 (0.79–5.96)	0.134
Non ST-elevation myocardial infarction	1.35 (0.46–3.96)	0.585

OR odds ratio, CI confidence interval, PCI percutaneous coronary intervention, CABG coronary artery bypass grafting, TIA transient ischemic attack, ACEI angiotensin-converting enzyme inhibitor, ARB angiotensin II receptor blocker